- Home
- MREO vs RGC Comparison
MREO vs RGC Comparison
Compare MREO & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- RGC
- Stock Information
- Founded
- MREO 2015
- RGC 2014
- Country
- MREO United Kingdom
- RGC Hong Kong
- Employees
- MREO N/A
- RGC N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- RGC Medicinal Chemicals and Botanical Products
- Sector
- MREO Health Care
- RGC Health Care
- Exchange
- MREO Nasdaq
- RGC Nasdaq
- Market Cap
- MREO 424.5M
- RGC 377.5M
- IPO Year
- MREO N/A
- RGC 2021
- Fundamental
- Price
- MREO $2.15
- RGC $877.00
- Analyst Decision
- MREO Strong Buy
- RGC
- Analyst Count
- MREO 7
- RGC 0
- Target Price
- MREO $7.71
- RGC N/A
- AVG Volume (30 Days)
- MREO 943.2K
- RGC 94.8K
- Earning Date
- MREO 05-13-2025
- RGC 06-20-2025
- Dividend Yield
- MREO N/A
- RGC N/A
- EPS Growth
- MREO N/A
- RGC N/A
- EPS
- MREO N/A
- RGC N/A
- Revenue
- MREO N/A
- RGC N/A
- Revenue This Year
- MREO N/A
- RGC N/A
- Revenue Next Year
- MREO $54.91
- RGC N/A
- P/E Ratio
- MREO N/A
- RGC N/A
- Revenue Growth
- MREO N/A
- RGC N/A
- 52 Week Low
- MREO $1.58
- RGC $3.03
- 52 Week High
- MREO $5.02
- RGC $950.00
- Technical
- Relative Strength Index (RSI)
- MREO 40.94
- RGC 80.93
- Support Level
- MREO $2.12
- RGC $476.79
- Resistance Level
- MREO $2.27
- RGC $560.00
- Average True Range (ATR)
- MREO 0.13
- RGC 127.64
- MACD
- MREO -0.02
- RGC 39.03
- Stochastic Oscillator
- MREO 9.09
- RGC 89.80
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.